Facial Injectables Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Facial Injectables Market Growth & Trends. The market is Segmented by Type (Wrinkle Relaxers (Botulinum Toxin) and Dermal Fillers (Collagen, Hyaluronic Acid, Fat Injection, Polylactic Acid, Polymethyl-methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, and Other Dermal Fillers), Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Other Application), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Facial Injectables Market Size

Single User License
Team License
Corporate License
Book before:
Facial Injectables Market Summary
share button
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 12.20 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Facial Injectables Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Facial Injectables Market Analysis

The facial injectables market is expected to register a CAGR of 5.8% over the forecast period.

The outbreak of the pandemic impacted the facial injectables market adversaly. For instance, according to the July 2022 NCBI research article, based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020. In addition, a large number of cases of COVID-19 across the globe had a slight negative short-term impact on surgical rates for cosmetic procedures in the initial outbreak phase. However, owing to the resumption of elective services and cosmetic procedures around the world in 2021 and 2022, the market started to gain traction and is expected to continue the upward trend over the forecast period.

The rising aesthetic consciousness and the number of cosmetic procedures, the introduction of cost-effective facial injectables, and the aging population are some of the major factors propelling the market's growth. The cosmetics industry has witnessed a boom over the past decade. In particular, there has been an increase in the total number of non-surgical procedures, such as injections of wrinkle relaxers and dermal fillers, due to the surge in aesthetic appeal and availability of highly advanced aesthetic procedures. This trend is primarily due to the advantages of technology, such as low recovery times, a lower risk of infection, no blood loss, and an overall reduction in procedural costs. For instance, according to the 2021 International Society of Aesthetic Plastic Surgery (ISAPS) report, more than 10,129,528 cosmetic surgical procedures were performed in 2021. The top non-surgical procedures in 2021 include calcium hydroxylapatite (222,785), poly-L-lactic acid (121,087), botulinum toxin, and hyaluronic acid. Therefore, such a high number of facial injectable procedures is anticipated to spur market growth over the forecast period.

In addition, there is a consistent rise in the geriatric population, which helps boost the market's growth. For instance, according to the 2021 WHO report, by 2030, 1 out of every 6 people across the globe will be 60 years of age or older. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of people aged 60 and above will reach 2.1 billion. Between 2020 and 2050, the number of people aged 80 and above is expected to triple, reaching 426.0 million. Since the geriatric population is the major target group for cosmetic procedures, increasing the geriatric population is likely to boost the market's growth over the forecast period.

The market players are adopting various strategies, such as product launches, developments, collaborations, partnerships, acquisitions, and expansions, to increase their market share. For instance, in September 2021, Aesthetics Innovators launched two new injectables into the aesthetics sphere: MaiLi, a hyaluronic acid (HA) dermal filler that uses less product than traditional fillers, and Lanluma, an industry-first collagen-stimulating filler for the body. As a result, such innovations are expected to create new opportunities for the market, propelling market growth.

However, the side effects of available products and the lack of reimbursement policies supporting cosmetic procedures may impede the market's growth over the forecast period.

Facial Injectables Market Trends

This section covers the major market trends shaping the Facial Injectables Market according to our research experts:

Hyaluronic Acid Segment is Expected to Hold Significant Share Over the Forecast Period

The hyaluronic acid sub-segment is anticipated to dominate the dermal fillers segment over the coming years. Some of the factors responsible for hyaluronic acid segment growth include its ability to store moisture in the skin, thus making the skin look healthier. This moisture-binding characteristic helps enhance and maintain the vital moisture responsible for the plumpness of the facial skin. Hyaluronic acid has significant benefits as it increases hydration, improves elasticity, and reverses free radical damage while protecting from UV damage. Thus, the advantages of hyaluronic acid are likely to boost the segment's growth over the forecast period.

The increasing use of hyaluronic acid dermal fillers is one of the major drivers for the segment. For instance, according to a June 2022 NCBI research study, due to the simplicity of administration of hyaluronic acid, the rapid onset of effect, and short patient recovery times, hyaluronic acid (HA) dermal fillers are one of the most popular nonsurgical techniques in aesthetic medicine. Similarly, according to the December 2021 International Society of Aesthetic Plastic Surgery report, hyaluronic acid was listed among the top 5 non-surgical aesthetic procedures in 2021. It was also reported that more than 4,053,016 hyaluronic acid procedures were performed in 2021. Thus, such a high number of procedures across the globe are responsible for the dominance of the segment.

Moreover, the market players are adopting various strategies, such as product launches, developments, collaborations, partnerships, acquisitions, and expansions, to increase their market share. For instance, in August 2022, a TGA-approved bio remodeling injectable was launched in Australia, which is made up of stabilized hybrid cooperative complexes (HCC) of high and low molecular weight ultra-pure hyaluronic acid in high concentration. The injectable works by slowly releasing hyaluronic acid into the skin to stimulate the production of collagen, elastin, and adipose (fat) cells.

So, because of the things listed above, the studied segment is likely to grow a lot over the next few years.

Facial Injectables Market - Total Number of Dermal Fillers Procedures (in millions), By Gender, United States, 2021

North America is Expected to Witness Considerable Share Over the Forecast Period

North America is expected to dominate the overall facial injectables market, over the forecast period. The growth is due to factors such as higher awareness about aesthetic surgical procedures, technological advancements in cosmetic procedures, the presence of key market players, the increasing geriatric population, and the growing demand for non-invasive aesthetic procedures. For instance, as per the Statistics Canada 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females. The demand for aesthetic fillers is expected to increase due to increased attention to geriatric aesthetics among this age group, thereby propelling market growth in the North American region.

Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing demand for non-surgical aesthetic procedures in the United States are some of the factors driving the growth of the facial injectables market in the country. For instance, in February 2022, Allergan Aesthetics, an Abbvie company, received U.S. FDA approval for JUVÉDERM VOLBELLA XC for the improvement of infraorbital hollows in adults over the age of 21.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Facial Injectables Market - Growth Rate by Region

Facial Injectables Industry Overview

The facial injectables market is moderately competitive. The companies are also focusing on expanding their presence in emerging markets and maintaining strong distributor relationships. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including AbbVie Inc. (Allergan Plc), Ipsen SA, Medytox Inc., Merz Pharma, and Sinclair Pharma Plc, among others.

Facial Injectables Market Leaders

  1. AbbVie Inc (Allergan Plc)

  2. Ipsen SA

  3. Medytox Inc.

  4. Merz Pharma

  5. Sinclair Pharma Plc

*Disclaimer: Major Players sorted in no particular order

Facial Injectables Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Facial Injectables Market News

  • August 2022: Allergan Healthcare India launched Juvéderm VOLUX, an injectable implant intended to restore and create the volume of the face, under its Business Unit of Allergan Aesthetics.
  • February 2022: Merz Aesthetics launched Radiesse (+) as the first and only aesthetic injectable to improve moderate to severe loss of jawline contour.

Facial Injectables Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Aesthetic Consciousness and Number of Cosmetic Procedures

      2. 4.2.2 Introduction of Cost-effective Facial Injectable

      3. 4.2.3 Ageing Population

    3. 4.3 Market Restraints

      1. 4.3.1 Side-effects of Available Products Limiting Adoption

      2. 4.3.2 Lack of Reimbursement Policies Supporting Cosmetic Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Type

      1. 5.1.1 Wrinkle Relaxers

        1. 5.1.1.1 Botulinum Toxin

      2. 5.1.2 Dermal Fillers

        1. 5.1.2.1 Collagen

        2. 5.1.2.2 Hyaluronic Acid

        3. 5.1.2.3 Fat Injection

        4. 5.1.2.4 Polylactic Acid

        5. 5.1.2.5 Polymethyl-methacrylate Microspheres (PMMA)

        6. 5.1.2.6 Calcium Hydroxylapatite

        7. 5.1.2.7 Other Dermal Fillers (Polyalkylimide etc.)

    2. 5.2 By Application

      1. 5.2.1 Facial Line Correction

      2. 5.2.2 Lip Augmentation

      3. 5.2.3 Face Lift

      4. 5.2.4 Acne Scar Treatment

      5. 5.2.5 Lipoatrophy Treatment

      6. 5.2.6 Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc (Allergan Plc)

      2. 6.1.2 Anika Therapeutics Inc.

      3. 6.1.3 Ipsen SA

      4. 6.1.4 Medytox Inc.

      5. 6.1.5 Merz Pharma

      6. 6.1.6 Galderma Pharma SA

      7. 6.1.7 Sanofi SA

      8. 6.1.8 Sinclair Pharma Plc

      9. 6.1.9 Suneva Medical Inc.

      10. 6.1.10 Alphaeon Corporation (Teoxane Laboratories)

      11. 6.1.11 Bloomage Biotechnology (Laboratories Vivacy SAS)

      12. 6.1.12 SciVision Biotech Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Facial Injectables Industry Segmentation

As per the scope of the report, facial injectables aid in rejuvenating the facial skin by reducing wrinkles, raising scar depression, and enhancing the lips. Facial injectables are products that include collagen and hyaluronic acid fillers, as well as synthetic fillers, such as calcium hydroxylapatite. Injectable products, such as hyaluronic acid, increase skin hydration, improve skin, protect from UV damage, and have relatively few side effects. The Facial Injectables Market is Segmented by Type (Wrinkle Relaxers (Botulinum Toxin) and Dermal Fillers (Collagen, Hyaluronic Acid, Fat Injection, Polylactic Acid, Polymethyl-methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, and Other Dermal Fillers), Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Other Application), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The report also covers the estimated market sizes and trends for 17 countries across global regions. The report offers the value (in USD million) for the above segments.

By Type
Wrinkle Relaxers
Botulinum Toxin
Dermal Fillers
Collagen
Hyaluronic Acid
Fat Injection
Polylactic Acid
Polymethyl-methacrylate Microspheres (PMMA)
Calcium Hydroxylapatite
Other Dermal Fillers (Polyalkylimide etc.)
By Application
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Facial Injectables Market Research FAQs

The Facial Injectables Market is projected to register a CAGR of 12.20% during the forecast period (2024-2029)

AbbVie Inc (Allergan Plc), Ipsen SA, Medytox Inc., Merz Pharma and Sinclair Pharma Plc are the major companies operating in the Facial Injectables Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Facial Injectables Market.

The report covers the Facial Injectables Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Facial Injectables Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Facial Injectables Industry Report

Statistics for the 2024 Facial Injectables market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Facial Injectables analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Facial Injectables Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)